The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1966, 96: 261-267.
Copyright © 1966 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benyesh-Melnick, M.
Right arrow Articles by Wimberly, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benyesh-Melnick, M.
Right arrow Articles by Wimberly, I.

Human Cytomegalovirus: Properties of the Complement-Fixing Antigen1

Matilda Benyesh-Melnick, Vladimir Vonka2, Fern Probstmeyer and Ira Wimberly

From the World Health Organization International Reference Centre for Enteroviruses, Department of Virology and Epidemiology, Baylor University College of Medicine, Houston, Texas

Abstract

The correlation between infectivity, virus particle counts, and complement-fixing activity was studied with cell-associated and fluid phase preparations of two strains of human cytomegalovirus. CF antigen was detected only in cellassociated virus preparations and was not found in fluid phase virus preparations. The CF antigen obtained from cell-associated virus preparations was found to be stable at 4°C but was unstable at 37°C, which is just the reverse behavior of cytomegalovirus infectivity. When subjected to ultracentrifugation at speeds which sedimented virtually all of the virus particles, about 50% of the CF antigen behaved as a subviral "soluble" component and remained in the supernatant fluid.

Footnotes

1 This study was supported in part by Research Grant CA-04600 from the National Cancer Institute and by Training Grant 5 T1 AI 74 and Research Grant AI 05382 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States Public Health Service.

2 World Health Organization Senior Research Fellow.

Present address: Virus Research Department, Institute of Sera and Vaccines, Prague, Czechoslovakia.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1966 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1966 by The American Association of Immunologists, Inc. All rights reserved.